Europe — EMA
Nebivolol Teva
GNH USA supplies Nebivolol Teva (Nebivolol), a beta‑blocker for essential hypertension and chronic heart failure. Request a quote for global supply.
Request sourcing
What is Nebivolol?
Nebivolol, the active ingredient in Nebivolol Teva, is a beta‑blocker presented as an oral tablet for oral use. It treats essential hypertension and chronic heart failure in adults.
GNH USA supplies Nebivolol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Nebivolol used for?
Nebivolol acts on the cardiovascular system to lower blood pressure and improve cardiac function.
Essential hypertension: reduces systolic and diastolic blood pressure, helping to control primary hypertension. Chronic heart failure: improves left‑ventricular ejection fraction and reduces symptoms such as dyspnea. Left‑ventricular systolic dysfunction: enhances cardiac output and may lower the risk of hospitalization.
What are the side effects of Nebivolol?
Nebivolol is generally well tolerated, but adverse reactions can occur.
Common Side Effects: - Headache - Dizziness - Fatigue - Bradycardia - Nausea - Insomnia
Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm in patients with reactive airway disease - Allergic skin reactions or angioedema - Hepatic enzyme elevation - Acute heart failure decompensation
What precautions apply to Nebivolol?
Nebivolol should be used with clinical vigilance in several situations.
Monitor blood pressure: ensure adequate control without excessive drop. Assess heart rate: avoid severe bradycardia. Use caution in asthma or COPD: β1‑selectivity may still affect bronchial tone. Review renal and hepatic function: dose adjustment may be needed. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Store at room temperature: keep in the original pack, protect from moisture.
What does Nebivolol interact with?
Nebivolol can interact with other medicines; some require avoidance while others need monitoring.
Major Interactions (Avoid): - Concomitant use with other β‑blockers or non‑selective β‑blockers may cause excessive cardiac depression. - Calcium‑channel blockers such as verapamil or diltiazem can increase AV‑node conduction delay. - Potent CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) may raise nebivolol plasma levels.
Moderate Interactions (Monitor Closely): - NSAIDs may blunt the antihypertensive effect. - Diuretics can potentiate hypotension and electrolyte disturbances.



